Tonix Pharmaceuticals Receives IND Clearance for TNX-201 in Episodic Tension-Type Headache October 21, 2014 • 8:40 AM EDT
Tonix Pharmaceuticals Reports Top Line Results From Phase 2b BESTFIT Trial of TNX-102 SL in Patients With Fibromyalgia September 29, 2014 • 6:00 AM EDT
Tonix Pharmaceuticals to Present at the BioCentury NewsMakers Conference September 19, 2014 • 8:40 AM EDT
Tonix Pharmaceuticals to Present at the Rodman & Renshaw Global Investment Conference September 3, 2014 • 8:40 AM EDT
Tonix Pharmaceuticals Announces Registered Direct Offering of $7.8 Million July 11, 2014 • 8:20 AM EDT